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native binding sites within chromatin and
drive the inclusion of telomeric
sequences within the genome, creating
sites prone to breakage and
translocations.
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The breakage-fusion-bridge cycle is a classical
mechanism of telomere-driven genome instability in
which dysfunctional telomeres are fused to other
chromosomal extremities, creating dicentric chro-
mosomes that eventually break at mitosis. Here,
we uncover a distinct pathway of telomere-driven
genome instability, specifically occurring in cells
that maintain telomeres with the alternative length-
ening of telomeres mechanism. We show that, in
these cells, telomeric DNA is added to multiple
discrete sites throughout the genome, correspond-
ing to regions regulated by NR2C/F transcription
factors. These proteins drive local telomere DNA
addition by recruiting telomeric chromatin. This
mechanism, which we name targeted telomere inser-
tion (TTI), generates potential common fragile sites
that destabilize the genome. We propose that TTI
driven by NR2C/F proteins contributes to the forma-
tion of complex karyotypes in ALT tumors.INTRODUCTION
Cancer is characterized by genomic alterations that lead to
oncogene activation and/or tumor suppressor loss. These
changes accumulate during tumor development and can be de-
tected as translocations, amplifications, or deletions of chromo-
somal segments. Another major characteristic of cancer cells is
their unlimited proliferative potential. This feature is dependent
on the activation of a telomere maintenance mechanism upon
exit from crisis (Hanahan andWeinberg, 2011). During cell crisis,
genome instability and telomere dysfunction have been primarily
linked through the classical mechanism of breakage-fusion-
bridge cycle (BFB) first described by Barbara McClintock
(McClintock, 1941). In this chain of events, unprotected or
broken telomeres can fuse to another chromosomal extremity
via non-homologous end joining. Fusions create di-centric chro-
mosomes that eventually break at random positions duringmitosis, generating deletions and amplifications of chromosomal
segments and more unprotected chromosome ends (Murnane,
2012). This cycle persists until chromosomal extremities get sta-
bilized by telomere addition via telomerase activation. In human,
telomerase is activated in the majority of cancers. However, in a
subset of tumors,mostly sarcomas, telomeres aremaintained by
a recombination/amplification mechanism termed alternative
lengthening of telomeres (ALT) (Bryan et al., 1997). These tumors
typically harbor highly heterogeneous and complex karyotypes
(Taylor et al., 2011). The lack of apparent specific translocations
makes it challenging to identify the mechanism driving tumori-
genesis in these cancers. Efforts to characterize these tumors
are thus currently limited to identifying specific gene expression
signatures (Chibon et al., 2010). Similarly, the mechanism under-
lying ALT activation and maintenance in these tumors is un-
known. Because tumors in which telomerase is inhibited can
activate ALT in mouse models (Hu et al., 2012), it is critical to
dissect this pathway to design efficient anti-cancer therapies
targeting telomere maintenance. We previously showed that
orphan nuclear receptors of the NR2C/F classes (TR2, TR4,
COUP-TF1, COUP-TF2, and EAR2), which belong to the nuclear
hormone receptor (NHR) family of transcription factors, are aber-
rantly associated with telomeres in a prototypic ALT(+) cell line
(De´jardin and Kingston, 2009). This finding was unexpected, as
transcription factors usually associate with gene regulatory re-
gions, and telomeres do not contain classical genes. Here, we
address the biological relevance of this finding.We identify a crit-
ical role for these proteins in the ALT process and in active desta-
bilization of the genome. We dissect the mechanism leading to
their aberrant recruitment to telomeres, and we show that these
proteins have a major architectural role: NR2C/F proteins can
bridge together bound loci in the nuclear space. By promoting
spatial proximity, NR2C/F proteins favor the telomere-telomere
recombination necessary for ALT maintenance. Surprisingly,
NR2C/F-driven spatial proximity also induces the tethering of
telomeric chromatin to hundreds of regular NR2C/F-binding
sites throughout the genome. This abnormal organization trig-
gers the insertion of telomeric material to these sites, and this
process depends on NR2C/F proteins. Insertions of telomeric
DNA throughout the genome lead to the creation of potential
common fragile sites that are known to be prone to breakageCell 160, 913–927, February 26, 2015 ª2015 Elsevier Inc. 913
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Figure 1. Analysis of the Binding Profile of NR2C/F Factors at Telomeres by ChIP Sequencing
(A) Normalized amount of telomeric reads in ALT() (pink) and ALT(+) (red) libraries prepared from input DNA, TRF2, NR2F/C2, and HMBOX1 IPs (dashed line
displays normalized amount in input libraries).
(legend continued on next page)
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and translocations. Because this mechanism of telomere-driven
genome instability is fundamentally distinct from the BFB cycles
and occurs as the consequence of the activation of a telomere
maintenance mechanism, we name it targeted telomere inser-
tions (TTI). In line with the role played by NR2C/F factors in TTI,
we show that these proteins associate with telomeres in primary
ALT tumors in situ and that this association correlates with the
extent of karyotype rearrangements. Therefore, NR2C/F have a
critical role in ALT and in the activation of TTI. We propose that
this mechanism of telomere-driven genome instability induces
heterogeneous genomes and contributes to the generation of
complex karyotypes in ALT sarcomas (Taylor et al., 2011).
RESULTS
NR2C/F Factors Bind to Direct Repeats of a Variant
Telomeric Motif
To get insights into the significance of NR2C/F binding to telo-
meres, we first examined how these factors are recruited. A
mutant NR2C2 protein with point mutations disrupting DNA
binding (Tanabe et al., 2007) fails to accumulate at telomeres
(Figures S1A and S1B), suggesting that NR2C/F directly bind
to DNA. NHR usually associate with DNA as dimers by bind-
ing to a composite sequence made of two half-sites (the
50-A/GGGTCA-30 motif). Depending on the mutual orientation
and spacing of these half-motifs, the full binding site varies
extensively (Sandelin and Wasserman, 2005). Since the NHR
half-site is related to the canonical telomere basic repeat unit
50-GGGTTA-30, we hypothesized that NR2C/F could be recruited
to ALT telomeres through binding to an iteration of the naturally
occurring variant 50-GGGTCA-30 (Allshire et al., 1989).We thus
analyzed by chromatin immunoprecipitation (ChIP) combined
with high-throughput sequencing the DNA sequences associ-
ated with NR2C2 and NR2F2, those associated with the canon-
ical telomere-binding protein TRF2 (de Lange, 2005), and with
HMBOX1, another DNA-binding protein that we previously iden-
tified at telomeres regardless of the maintenance mechanism
(De´jardin and Kingston, 2009). This analysis was performed in
both ALT(+) and in ALT() cell lines (WI-38 VA13 2RA and
HeLa 1.2.11 cells, respectively) using validated antibodies (Fig-
ures S2A, S4A, and S7A). While TRF2 and HMBOX1 are enriched
at both types of telomeres, NR2C2/F2 proteins bind only to
ALT(+) telomeres (Figures 1A and S2A), consistent with our orig-
inal findings (De´jardin and Kingston, 2009). Even when overex-
pressed, these factors cannot be detected at ALT() telomeres
(Figure S1D), ruling out an effect due to differences in the expres-(B) TTAGGG content of telomeric reads in IPs from ALT() (left) and ALT(+) (right
containing one to eight TTAGGG occurrences. Red brackets highlight subsets of t
enriched in ALT(+) libraries.
(C) Percentage of telomeric reads containing the indicated repeat variant in ALT(+
IPs. Variant repeats were identified within telomeric reads that contained three or
telomeric reads from ALT(+) NR2C/F libraries.
(D) Pie charts showing that GGGTCA multimerization is specific for ALT(+) telome
GGGTCA (left) or NHR unrelated variant ‘‘GGGTTG’’ (right) occurrences (n indicat
in ALT(+) and ALT() input libraries). GGGTTG is used as a control to show that
(E) Normalized number of telomeric reads containing GGGTCA DR0, DR6, DR7,
receptors NR2F/C IPs.
See also Figures S1 and S2.sion level. To further characterize the binding mode of these
factors, immunoprecipitated sequences were categorized ac-
cording to their content in the canonical telomere motif GGGTTA
(from one to eight occurrences in each 50-nt-long sequencing
read). The canonical telomere motif has a similar distribution in
the TRF2 and HMBOX1 libraries, implying similar binding speci-
ficity in both cell types (Figure 1B). In these libraries, the majority
of enriched reads contains seven or eight occurrences of the
canonical motif, suggesting that TRF2 and HMBOX1 bind to
the canonical telomere sequence in vivo, as expected (Bilaud
et al., 1997; Broccoli et al., 1997; Kappei et al., 2013). In contrast,
reads associated with NR2C2/F2 showed a different distribution
of GGGTTA occurrences, indicating a distinct binding specificity
(Figure 1B). To characterize the motifs that allow specific
NR2C2/F2 binding, we analyzed these reads further (red
brackets in Figure 1B) and found that, among all possible se-
quences, the GGGTCA motif was specifically enriched in
NR2C2/F2 reads (Figure 1C). This is in agreement with the clas-
sical sequence-specific binding mode for NHR and our original
hypothesis (Benoit et al., 2006; De´jardin and Kingston, 2009;
Conomos et al., 2012). Although less frequent (by 6-fold), the
GGGTCA motif is also present in ALT() telomeres, indicating
that the simple presence of the motif is not sufficient to promote
NR2C/F recruitment. Thus, we analyzed the occurrence of the
NHR motif in telomeric reads. GGGTCA is essentially found as
a multimer in ALT(+) sequences and as a monomer in ALT()
reads (Figure 1D), suggesting that NR2C/F cannot be recruited
to single GGGTCA motif at telomeres. Since these data suggest
a classical binding mode for NR2C/F factors, we searched for
the full binding sites for these proteins. We identified the direct
repeats DR0, DR6, and DR7 (two half-sites in the same orienta-
tion and separated by 0, 6, or 7 nucleotides) as the major NR2C/
F-binding sites at telomeres (Figure 1E), and these sites are, at
least for DR0, 80-fold enriched in ALT(+)compared to ALT()
telomeric DNA. Therefore, NR2C/F recruitment is promoted by
the presence of DR0, 6, and 7 motifs specifically in ALT
telomeres.
The Telomere Protein TRF2 Binds to Hundreds of
NR2C/F Regions throughout the Genome of ALT Cells
The aberrant recruitment of NR2C/F factors could suggest that
telomeres potentially act as ‘‘molecular sinks’’ for these tran-
scription factors in ALT cells. Titration could impinge on the bind-
ing and the regulation of NR2C/F targets, which would indirectly
control ALT and/or tumorigenesis (Safe et al., 2014). Therefore,
we analyzed the genome-wide binding profile of NR2C2 and) cells. Histograms display for each library the percentages of telomeric reads
elomeric reads containing three or four TTAGGG occurrences that are strongly
) and ALT() libraries prepared from input DNA, TRF2, NR2F/C, and HMBOX1
four TTAGGG occurrences and were sorted based on their relative amount in
res. The charts display the number of telomeric reads containing one to seven
es the number of telomeric reads containing the GGGTCA or GGGTTG variants
multimerization is specific for the GGGTCA motif.
and DR12 in libraries prepared from ALT() input and ALT(+) input and orphan
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Figure 2. TRF2 Binds to Hundreds of Loci throughout the Genome in ALT Cells
(A) Overlap between TRF2- and NR2F/C-binding sites genome wide. (Top) Venn diagrams displaying peak overlap (values indicate the number of peaks).
(Bottom) Average read densities in NR2F/C libraries relative to the TRF2 peaks.
(B) Density profiles of input, TRF2, and NR2F/C reads in two representative loci in ALT() and ALT(+). TRF2 is only bound in ALT(+).
(C) Chromosomal locations of ALT(+) TRF2 peaks, ALT(+) NR2C/F peaks overlapping with TRF2 peaks, and ALT(-)NR2C/F peaks.
(legend continued on next page)
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NR2F2 and concluded that ALT(+) telomeres do not titrate these
transcription factors since we identify more binding regions in
ALT(+) than in ALT() genomes (Figure 2A). We also analyzed
the genomic distribution of TRF2, as it supposedly binds not
only to telomeres, but also to rare interstitial telomeric se-
quences (ITS) (Simonet et al., 2011). ITS contain a various num-
ber of iterations of the GGGTTA motif explaining TRF2
recruitment and are well-characterized common fragile sites
(CFS) (Bosco and de Lange, 2012). Surprisingly in ALT(+) cells,
we identified several hundreds of TRF2-binding sites (Figure 2A)
that are not mapping to known ITS. However, most of these sites
(75%) overlap with binding sites for NR2C2/F2 proteins (Figures
2A and 2B). Importantly, none of these regions were bound by
TRF2 in ALT() cells, pointing to an ALT-specific binding mode
for TRF2 (Figure 2B). In contrast, in ALT() cells, TRF2 binds
only to 45 regions, 20 of which corresponded to known ITS often
located in subtelomeric regions (Simonet et al., 2011) (Figures
2A–2C). Interestingly, when we looked at the position of these
sites with respect to genes, we found that the NR2C2 regions
that also recruit TRF2 have a broad distribution and are usually
located far from gene promoters (Figure 2D). In contrast, the
TRF2-negative NR2C2 regions are principally located at gene
transcription start sites. Moreover, the sequence content of
these two populations is different. The classical promoter-bound
NR2C2 regions are enriched in the expected motifs, in particular
the ETS binding sequence (O’Geen et al., 2010) (Figure 2E). On
the other hand, the non-genic NR2C2 regions bound by TRF2
lack the ETS motif but are highly enriched in the GGGTCA motif
(81% reads). Remarkably, most of these sites (87%) also lack
the canonical telomere sequence, excluding a classical DNA-
mediated recruitment mechanism for TRF2. Thus, our data point
to an unusual recruitment mode for TRF2 throughout the
genome of ALT cells.
NR2C/F Proteins Induce Spatial Proximity of Their
Binding Loci
A simple interaction between TRF2 and NR2C2/F2 only in ALT(+)
cells is unlikely because a large number of NR2C2/F2 sites
remain TRF2 free. Moreover, we failed to detect any interaction
between TRF2 and NR2C/F proteins by coimmunoprecipitation
(data not shown). Additionally, the absence of telomeric motifs
at NR2C2/F2 sites likely excludes a direct TRF2 recruitment.
Thus, we hypothesized that physical interactions between ALT
telomeric material and endogenous NR2C/F-binding sites occur
via NR2C/F proteins (Figure 3A). Accordingly, NR2C/F proteins
would bridge ALT telomeres and extra-chromosomal telomeric
material generated by the recombination process (Cesare and
Griffith, 2004) together and to endogenous NR2C/F regions. By
carrying over telomeric material, TRF2 is most probably cross-
linked by formaldehyde ‘‘in trans’’ at endogenous NR2C/F re-
gions, resulting in the appearance of enrichment peaks for
TRF2 throughout the ALT genome at NR2C/F binding regions.(D) Distribution of NR2C2 peaks overlapping (+) or not () with TRF2 peaks in
transcriptional start site (promoter, TSS). (Bottom) Boxplots showing the distribu
(E) Overrepresented motifs in NR2C2 peaks overlapping (+) or not () with TRF2 p
central peak positions, and values indicate the percentage of peaks containing t
See also Figures S1 and S2.The same bridging feature would explain why telomeres exten-
sively interact with each other in ALT cells. Classical methods
to measure locus interactions like chromosome conformation
capture (Dekker et al., 2002) are challenging for repetitive se-
quences like telomeres. Thus, to test telomere bridging by these
factors, we used super-resolution three-dimensional structured
illumination microscopy (3D-SIM), which improves spatial reso-
lution by a factor of eight (Gustafsson et al., 2008).We expressed
the DNA-binding mutant NR2C2 protein in the SaOS-2 ALT cell
line. This mutant acts as a dominant-negative for endogenous
NR2C2 (Tanabe et al., 2007), stripping it off telomeres (Fig-
ure S1C). In SaOS-2 cells, NR2C2 is the only orphan nuclear re-
ceptor bound to telomeres, suggesting that no other NHR could
compensate for NR2C2 loss. The expression of this mutant dis-
rupts telomere-telomere interactions, as shown by super-resolu-
tion microscopy (Figure 3B). The number of telomeric clusters is
reduced, and this is accompanied by an increase in the number
of single detectable telomere signals (Figures 3B–3E, S3A, and
S3B). On the other hand, expression of the mutant form of
NR2C2 in HeLa 1.2.11 ALT() line has no effect on telomere
number (Figure S4C). Similar results were obtained upon simul-
taneously knocking down NR2C1, NR2C2, and NR2F2 (NR2C/F)
proteins in the WI38-VA13 ALT cell line (Figures S4A and S4B).
Next, to evaluate bridging between telomeric material and non-
telomeric NR2C/F regions, we developed an independent assay.
In this approach, the sub-nuclear localization of a fluorescent
plasmid DNA harboring NR2C/F DR0-binding sites can be
tracked (Figure S3C). If our bridging hypothesis is valid, this
plasmid should be targeted to ALT(+) telomeres, which concen-
trate NR2C/F proteins. In contrast, this plasmid should not
co-localize with ALT() telomeres, which are devoid of NR2C/F
factors. Indeed, despite the formation of large cytoplasmic ag-
gregates in transfected cells, which were unavoidable, the
plasmid is efficiently targeted to ALT(+), but not to ALT() telo-
meres (Figure S3C), whereas the control plasmid, not containing
NR2C/F binding motifs, does not accumulate at telomeres.
Moreover, this recruitment is NR2C/F dependent, as it disap-
pears upon NR2C/F depletion by RNAi. Next, we measured
whether NR2C/F tethering to a LacO transgenic locus non-
homologous to telomeric sequences is sufficient to drive the
proximity of that locus to ALT telomeres. We used a transgenic
U2-OS ALT cell line containing a single LacO array (Robinett
et al., 1996), in which we expressed a NR2C2-LacI fusion pro-
tein, able to bind to the LacO array in the absence of NHRbinding
motif. Tethering NR2C2-LacI to LacO leads to the extensive co-
localization of the array to telomeric clusters (85% co-localiza-
tion, Figure 3F), consistent with the bridging feature of this factor.
Unexpectedly, this also leads to the appearance of multiple
LacO signals co-localized with telomeric signals (82% of cells
were showing, on average, ten independent LacO foci), suggest-
ing a dramatic instability of the LacO array upon interaction with
ALT telomeres. Neither the tethering of GFP alone nor theALT(+) cells. (Top) Pie charts displaying categories according to the nearest
tion of NR2C2 peaks to the nearest TSS.
eaks in ALT(+) cells (red curves display the average location of the motif around
he motif).
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Figure 3. Locus Proximity Induced by NR2C/F Proteins
(A) Model of NR2C/F-induced proximity of telomeric and genomic sites. The samemodel applies to the telomere/telomere proximity necessary for recombination
in ALT.
(B) Telomere FISH showing ‘‘de-clustering’’ of telomeres (visible by 3D-SIM super resolution microscopy) and increased number of telomeric foci upon NR2C2-
DN expression in SaOS-2 cells, suggesting that telomere/telomere interactions are dissociated. The arrowheads indicate single telomeric foci within clusters.
Clusters were defined as single signals in the wide field mode, which could be resolved as at least two individual signals in super-resolution mode. Right panels
(legend continued on next page)
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tethering of NR2C2-LacI in a transgenic HeLa ALT() cell line
harboring a single LacO array leads to its telomeric re-localiza-
tion, or an amplification of LacO (Figures 3F and S3D). Alto-
gether, our data demonstrate that NR2C/F binding is necessary
for telomere-telomere proximity and for bridging bound loci to
telomeres in the nuclear space. The amplification of LacO in
the NR2C2 tethering experiment also suggests that bridging to
ALT telomeres likely induces instability of the co-localized locus.
Telomere DNA Insertions at NR2C/F Regions in the
Genome of ALT Cells
Physical interactions between translocating loci is a major
requirement for chromosomal translocations. In fact, transloca-
tions are primarily driven by the spatial organization of
chromosomes in the nucleus (Misteli and Soutoglou, 2009).
Chromosomal architecture must be highly perturbed in ALT cells
because ALT genomes show complex chromosome rearrange-
ments with multiple heterogeneous translocations (Guillou and
Aurias, 2010; Jain et al., 2010; Lovejoy et al., 2012). Since
NR2C/F proteins can drive the physical interaction of bound
loci and their apparent instability, we asked whether this feature
could trigger instability at endogenous NR2C/F loci. We hypoth-
esized that the genomic NR2C/F-binding sites interacting with
telomeric material could also be sites of telomere sequence
insertion. Telomeric DNA insertions at discrete genomic sites
should yield composite sequencing reads that fail to be aligned
to the reference genome. Thus, we focused our analysis on
sequencing reads that had mismatches. In both ALT(+) and
ALT() cell lines, 90% of the input libraries contain perfectly
mappable reads, suggesting comparably high sequencing qual-
ity (Figure S2B). Likewise, readsmapping to repeated DNA are of
comparably high quality (88% aligned perfectly). However,
while telomere reads from ALT() cells are also of high quality,
telomere reads from ALT(+) cells are more degenerated and
25% cannot be aligned without allowing mismatches (Fig-
ure S2B). To characterize this telomere specific discrepancy,
we analyzed TRF2 libraries in both ALT(+) and ALT() cells and
examined the sequence organization of the reads that could
not be aligned to the reference genome. This showed that,
among all possible random hexamers in rearranged sequences,
there is a striking bias for the canonical GGGTTA and the variant
GGGTCA motifs in ALT(+) samples (Figure 4A). This indicates
that, specifically in ALT cells, reads containing these motifs are
prone to rearrangements, regardless of their location in the
genome. We extended this analysis to NR2C2, NR2F2, and
HMBOX1 libraries. Reads in the NR2C2 and NR2F2 libraries
are even more degenerated than in the TRF2 and HMBOX1 li-
braries (Figures S2C and S2D), suggesting that NHR binding re-show the boxplot quantification of this effect. Top and bottom boxes show the fir
t test.
(C) Loss of telomere clustering upon NR2C2 DN expression (aggregate).
(D) Increase in detectable single telomere number.
(E) Distribution of telomeres as individual or clustered signals as measured by su
(F) (Left) FISH inU2-OS cells harboring the LacO transgenic array. Cells were tran
displaying the co-localization of LacO with telomere signals. (Right) Chart meas
dividual Lac signals in transfected cells. Right panel shows the boxplot quantificat
the mean. p values are from a two-sided Student’s t test.
See also Figures S3 and S4.gions are intrinsically more unstable. To get insights into the
nature of these rearranged sequences, we analyzed their con-
tent in details using the strategy depicted in Figure 4B. Strikingly,
these rearranged sequences are composed of a part mapping to
unique genome regions and aberrant random additions of
GGGTCA and/or GGGTTA sequences (Figure 4B, bottom), sug-
gesting that they can result from insertions of telomeric DNA.
These insertions do not occur at a precise position but are
always located close to (<30 nt) DR0 motifs. The systematic
presence of DR0 motifs in the non-rearranged portion of these
reads points to the involvement of NR2C/F proteins in targeting
the local rearrangement between ALT telomeric DNA and endog-
enous NR2C/F-binding sites. The few ALT() sequences that
could not be mapped to the genome contain mostly single-
nucleotide changes with no motif addition, suggesting that
they did not arise from telomeric DNA insertion. In ALT cells,
the rearranged reads map to 23 distinct genomic regions of
which 19 (82%) corresponded to TRF2-positive NR2C/F peaks
(Figure S6D). This indicates that only a small subset (19/473,
4%) of NR2C/F regions able to recruit telomeric material are
in fact loci for targeted telomeric insertions (TTI) in ALT cells.
NR2C/F-Driven Telomeric DNA Insertions at DNA
Double-Stranded Breaks Are Involved in Chromosomal
Translocations in ALT Cells
Artificial insertion of telomeric DNA inside genomes creates ITS,
and this has been shown to promote chromosome rearrange-
ments (Kilburn et al., 2001). Because ITS are potential common
fragile sites (Bosco and de Lange, 2012), addition of telomeric
DNA throughout the genome by TTI can be viewed as a source
of genome instability. As TTI parallels ALT, it must be an ongoing
mechanism in proliferating cells. To demonstrate that TTI is an
active process in ALT cells, we tried to provoke telomere
sequence addition throughout the genome. To this aim, we
induced DNA double-strand breaks (DSB) by drug treatments
or g irradiation and looked for telomere insertions at these sites
by scoring the number of ITS signals on metaphase chromo-
some spreads. Detectable ITS are more frequent in untreated
ALT(+) than ALT() chromosomes (5-fold), in line with our
sequencing data showing enrichment in telomeric sequences
at genomic sites in ALT(+) cells (Figure 5A). Upon DSB induction,
they double in ALT(+). No change was observed in ALT() chro-
mosomes, suggesting that breaks are normally repaired without
telomeric sequences added in this cell line (Murnane, 2012). In
ALT cells,30% of both pre-existing and newly formed ITS sites
are also bound by NR2C2 and 39% by TRF1, indicating their
telomeric origin (Figures 5B and 5C). Consistent with previous
data (Bosco and de Lange, 2012), these sites are potentiallyst and third quartile around the mean. p values are from a two-sided Student’s
per-resolution microscopy. p value from a two-sided Student’s t test.
sfected either with GFP-LacI (top) or Flag-NR2C2-LacI (bottom). (Middle) Chart
uring the extent of LacO signal amplification as counted by the number of in-
ion of this effect. Top and bottom boxes show the first and third quartiles around
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Figure 4. Degenerated Sequencing Reads
in ALT Cells Contain Telomeric Motifs
(A) Plot showing the frequency of degenerated
reads (R3 mismatches) containing different hex-
amers in ALT() and ALT(+) TRF2 IPs. Each dot
represents a different hexamer. Circled in red:
hexamers that are abundant in ALT(+), but not in
ALT().
(B) (Top) Flowchart displays the strategy to
identify ‘‘rearranged reads’’ (see Experimental
Procedures). Briefly, non-mappable 50-nt-long
reads were split in two 25-nt-long ‘‘trimmed’’ reads
that were then individually mapped onto the
genome. Non-mappable reads with at least one
‘‘trimmed’’ read that mapped uniquely were
considered as ‘‘rearranged.’’ (Bottom) Represen-
tative examples of rearranged and intact reads
mapping near a putative OR-binding site (DR0
underlined) of the Chr2 fusion ITS (reference
genome sequence from the hg18 assembly on the
top) retrieved from the TRF2 IP library in ALT (+)
(top) and ALT() (bottom) cells. Bold letters high-
light mismatched nucleotides relative to the refer-
ence sequence, and italic letters perfectly mapped
nucleotides. Red and green boxes highlight
GGGTTA and GGGTCA repeats, respectively,
found in the reference genomic sequence (light
color) or only in the rearranged reads (dark). As-
terisks highlight rearranged reads identified also in
the NR2F/C2 libraries. In the ALT() panel, the
arrows indicate single-nucleotide substitutions.fragile sites, as we observed increased breakage upon com-
bined TRF1 knockdown and aphidicolin treatments (Figure S5A).
TTI is NR2C/F dependent because no new ITS formed upon
NR2C1, NR2C2, and NR2F2 silencing (Figure 5C). Moreover,
NR2C/F-silenced cells have a significantly higher number of
chromosomal fusions (arrowheads in Figure 5D), mostly without
detectable telomeric signal. These fusions greatly increase upon920 Cell 160, 913–927, February 26, 2015 ª2015 Elsevier Inc.DSB induction (up to 30% of fused
chromosomes). This also suggests the
involvement of NR2C/F proteins in pre-
venting chromosomal fusions, a neces-
sary condition for the maintenance of
telomeric integrity in ALT cells. Similar re-
sults were also obtained in another ALT(+)
cell line and with another DNA-damaging
agent (Figure S5B), demonstrating that
telomere sequence addition to broken
chromosomal sites is common in ALT.
Moreover, because NR2C/F depletion
has no major effect on TRF1 and TRF2
levels (Figure S4A), this effect is unlikely
due to a shelterin defect but suggests a
protective role for NR2C/F factors on
ALT telomeres. Since internal telomeric
DNA has the inherent potential to form
common fragile sites (CFS) in the human
genome (Bosco and de Lange, 2012)
and telomeres are fragile sites (Sfeiret al., 2009), we reasoned that TTI should have the potential to
form translocations. Such translocations could leave telomeric
DNA between two chromosomal segments. DSB induced by g
irradiation in the VA13 cell line resulted in 88 unique random
break points on 693 analyzed chromosomes. 33% (29) of scored
translocations have detectable telomeric signals at the translo-
cation points between segments from distinct chromosomes,
as measured by SKY-FISH and telomere FISH on metaphase
spreads (Figures 5E and S6 and Table S1). Out of these 29
events, 13 do not involve terminal fusions, suggesting that TTI
occurs frequently (15% of scored translocations) when cells
are challenged. Thus, telomeric DNA likely participates in chro-
mosomal translocations in ALT cells.
Binding of NR2C/F Proteins to Telomeres Is a Hallmark
of ALT in Tumors and Correlates with the Extent of
Genome Rearrangements
To directly explore the link between NR2C/F association to telo-
meres, genome instability, and cancer in humans, we checked
whether these proteins can also be found on telomeres in hu-
man primary tumors. We analyzed 180 primary sarcomas from
the ‘‘complexity index in sarcoma’’ (CINSARC) signature collec-
tion (Chibon et al., 2010) by immunofluorescence and FISH on
tissue microarrays (see Table S2 for tumors data). ALT nuclei
contain structures called ALT-associated pro-myelocytic leuke-
mia bodies (APB), in which the telomeric DNA is abnormally
associated with the PML protein. The presence of APB is a diag-
nostic marker of ALT (Henson et al., 2005). Accordingly, we
scored 54.4% primary tumors analyzed as ALT(+) because
these tumors have detectable APB. This is in line with the
average ALT occurrence in sarcomas (Henson and Reddel,
2010), validating our approach. The vast majority of ALT(+) tu-
mors (79%) also show telomeric accumulation of NR2F2 or
NR2C2 (Figures 6A and 6B). We also analyzed healthy tissue
sections surrounding 12 distinct tumors, and none (0/12) show
NR2C2/F2 telomeric accumulation (Figure S7 and Table S3).
Thus, NR2C/F telomeric accumulations are cancer specific
and do not predate tumor development. Importantly, the extent
of NR2C/F association to telomeres correlates with the tumor
grade (25% in grades 1 and 2, versus 61% in grade 3) (Fig-
ure 6C). As tumor grade is a strong indicator of genome
complexity in sarcomas (Chibon et al., 2010), increased telo-
meric accumulation of NR2C/F proteins mirrors increased
genome rearrangements. This suggests the involvement of
NR2C/F proteins in generating complex karyotypes in human
sarcomas.
DISCUSSION
Telomeres are important protective chromosomal structures
that safeguard the genome. When telomeres are deprotected,
classical BFB cycles ensue and lead to genome alterations.
These alterations include deletions and amplifications of chro-
mosomal segments typically observed in tumors (Figure 7A).
The BFB cycles, although probably arising as a consequence
of the initial loss of important genome surveillance mecha-
nisms, favor the acquisition of oncogenic mutations or accel-
erate the loss of surveillance pathways that characterize
transformed cells (Artandi et al., 2000). Importantly, BFB cycles
are stopped when broken chromosomal extremities are
healed by the addition of telomeres. Chromosomal healing is
usually achieved by the reactivation of telomerase, which is
involved in the creation of functional telomeres. Therefore, it
is thought that the acquisition of telomere maintenance by
telomerase reactivation stabilizes the transformed genomeand favors an unlimited proliferation of selected transformed
cells. Here, we describe another mechanism of telomere-driven
genome instability that actually occurs as a consequence of the
activation of aberrant telomere maintenance (Figure 7B). In
contrast to the genome stabilization conferred by telomerase,
we show that ALT activation also directly destabilizes the
genome, using an unexpected mechanism that we name tar-
geted telomere insertion (TTI). We propose that TTI contributes
to the complex karyotypes found in tumors or cell lines in which
ALT is activated.
NR2C/F-Mediated Long-Distance Interactions
The massive recruitment of orphan nuclear receptors at telo-
meres in most ALT tumors or cell lines underlies a requirement
to maintain a critical function. Consistently, loss of these pro-
teins leads to defective telomere maintenance (Conomos
et al., 2012; De´jardin and Kingston, 2009) and chromosomal fu-
sions (Figure 5D). We found no evidence for a role of NR2C/F
proteins in transcribing telomeres (data not shown), but we
show here that this function is structural. By inducing the prox-
imity of their binding loci, NR2C/F proteins promote physical in-
teractions of telomeric material, a necessary requirement for
recombination. An unexpected consequence of this bridging
ability is that telomeric material is also able to physically interact
with non-telomeric NR2C2/F2-binding sites throughout chro-
mosomes. This represents a further confirmation that bridging
is a major feature of NR2C/F proteins. Intriguingly, not all
NR2C/F genomic sites have this ability. Telomere-genome inter-
actions usually occur at NR2C/F regions located at a distance
from genes, while promoters bound by NR2C/F do not seem
to be involved. We believe that the regions able to contact
telomeres might be enhancers because these elements are
known to interact at long distance and organize local chromo-
somal architecture (Smallwood and Ren, 2013). How would
regions bound by the same transcription factors be located in
close physical proximity? We can think of at least two possibil-
ities: either these proteins bind to a shared machinery/structure
available in limiting amounts, or these factors have the ability to
engage into homotypic interactions. In line with this, RXR
proteins, which belong to the NR2B family of NHR, have
been shown to be able to oligomerize in vitro (Chen and Prival-
sky, 1995). The biological significance of such architectural
ability is not totally clear, but the clustering of co-regulated re-
gions (presumably bound by the same factors) is a recurrent
feature. A benefit of clustering/compartmentalizing nuclear
transactions is to increase the local concentration of reactive
species to ensure the robustness of biological processes (De´jar-
din, 2012).
Targeted Telomere Insertions: Implications for Genome
Stability
Another NHR, the androgen receptor (AR), was shown to drive
the proximity of a subset of its target genes upon hormone in-
duction (Lin et al., 2009; Mani et al., 2009). Combined with gen-
otoxic stress, proximity is required to promote cancer-specific
translocations. We show here that the bridging function
conferred upon NR2C/F binding drives telomere sequence ad-
ditions throughout the genome upon genotoxic stress. Thus,Cell 160, 913–927, February 26, 2015 ª2015 Elsevier Inc. 921
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Figure 6. Telomeric NR2C/F Correlate with
Sarcoma Grades
(A) Most APB-positive sarcomas samples show
NR2C/F localization at telomeres. Immunofluo-
rescence (IF)/telomere FISH in grade 2 leiomyo-
sarcoma biopsies. (Top) APB scoring by co-local-
ization of the FISH signal (red) to PML bodies
(green). (Bottom) Localization of NR2C2 or NR2F2
(green) at telomeres (red) in the same tumors.
(B) Frequency of telomeric NR2C/F in APB(+) and
in APB() tumors based on the IF/FISH analysis.
p value from a two-sided t test.
(C) The frequency of NR2C2/F(+) telomeres in-
creases with the tumor grade. See Extended
Experimental Procedures for staining procedures.
See also Figure S7 and Tables S2 and S3.we believe that, in cancer cells, the bridging ability of transcrip-
tion factors, ordinarily used to modulate gene expression, is
frequently diverted to trigger chromosomal translocations. In
contrast to the well-defined translocation that AR controls in
prostate cancer, TTI yields heterogeneous rearrangements.
We think that TTI contributes to the appearance and mainte-
nance of complex mutator phenotypes at least at two levels:
(1) the ongoing insertions of telomeric DNA at regulatory re-Figure 5. Translocation Breakpoints Contain ITS in ALT Cells
(A) (Top) Outline of the ITS induction assay; (bottom) boxplot showing the percentage of chromosomes with
boxes show the first and third quartiles around the mean. p values are from a two-sided Student’s t test.
(B) IF/FISH showing localization of NR2C2 (green) to a DSB-induced ITS signal (red) on a metaphase chrom
(C) IF/FISH showing localization of TRF1 (red) to a DSB-induced ITS signal (green) on a metaphase chromo
(D) (Left) Telomeric FISHonchromosomespreadsofScrRNAi and triple knockdownVA13cells afterDSBdrug t
(arrows); mock, no treatment. (Right) Boxplot displaying induction of ITS sites in Scr RNAi and in triple of NR2
treated or not with a DSB inducing drug. Top and bottom boxes show the first and third quartiles around the m
(E) Boxplot quantification of the fusion events. Top and bottom boxes show the first and third quartiles around
t test.
(F) (Upper-left) SKY-FISH combined with telomere (green) and centromere (red) FISH showing interstitial tel
chromosomes 1, 7, 9, 15, and 18 in the ALT+ VA13 cell line. (Upper-right) Graphical representation of the
translocation events with or without ITS sites upon g irradiation. ter-ter, telomere-telomere translocations; ter-
telomere-genome translocations.
See also Figures S5 and S6 and Table S1.
Cell 160, 913–927,gions probably directly affect neigh-
boring gene regulation, and (2) inserted
telomeric DNA, which was shown to
be prone to breakage, can contribute
to elevated genomic instability. Our
sequencing analysis could not allow us
to measure the size of inserted telomeric
DNA, but the detection of newly formed
ITS by FISH (Figure 5C) suggests that
these additions could extend to several
kilobase pairs. Sarcomas in which ALT
is active have been shown to systemati-
cally harbor complex karyotypes with
non-specific translocations (Montgomery
et al., 2004; Scheel et al., 2001).
Although we cannot exclude that other
mechanisms could be involved, we pro-
pose that TTI contributes to generatinga subset of complex chromosomal rearrangements in these
cancers.EXPERIMENTAL PROCEDURES
Cell Culture
The U2-OS,WI-38 VA13 2RA (VA13 throughout the text), and Saos-2 cell lines
were obtained from ATCC. The HeLa 1.2.11 cell line was kindly provided byITS signals in different conditions. Top and bottom
osome (VA13 cells).
some (VA13 cells).
reatment (bleomycin) showingchromosome fusions
C1, NR2C2, and NR2F2 knocked down VA13 cells,
ean. p values are from a two-sided Student’s t test.
the mean. p values are from a two-sided Student’s
omeric signals at the translocation points between
rearranged chromosome. (Bottom) Distribution of
Cen, telomere-centomere translocations; gen-gen,
February 26, 2015 ª2015 Elsevier Inc. 923
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Figure 7. Comparison of TTI with BFB
(A) Outline of the BFB cycles. Instability is stopped by the acquisition of telomerase. (B) Outline of the TTI. Instability is further enhanced by ALT. Insertions of
telomeric DNA lead to the creation of potential fragile sites at endogenous NR2C/F binding regions. Two possible outcomes are highlighted upon breakage of
these sites, intra- or inter-chromosomal rearrangements.
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Titia de Lange. All were cultured in DMEM Glutamax (Life Technologies)
supplemented with 10% FBS (Eurobio). U2-OS and HeLa cell lines, harboring
single genomic insertions of the LacO array, were cultured with hygromycin B.
Cell Immunofluorescence
Staining was performed as described before (De´jardin and Kingston, 2009),
using the following antibodies: anti-TRF2 (Abcam [13579]); anti-PML (Santa
Cruz Biotechnology [sc-5621/sc-966]); anti-NR2C2 (PPMX [PP-H0107B-00]);
anti-HMBOX1 (Abcam [ab97643]); anti-NR2F2 (Abcam [ab50487]), anti-Flag
(Sigma [F7425]). Secondary antibodies: Jackson ImmunoResearch (anti-
rabbit DyLight 488 [711-485-152]; anti-mouse DyLight 488 [715-485-150];
anti-mouse DyLight549 [715-505-150]; anti-rabbit DyLight 549 [711-505-
152]; anti-mouse DyLight649 [715-495-150]; anti-rabbit DyLight 549 [711-
495-152]).
IF/FISH and FISH
After incubation with secondary antibodies, cells were cross-linked at 37C in
3.6% formaldehyde for 20 min and then incubated at 75C in 23SSC for 1 hr
and in 0.1M NaOH for 10 min and rinsed with 23SSC. Then, cells were dehy-
drated by successive 75% and 100% ethanol baths and air dried. Slides were
incubated at 82C with a telomeric-C PNA probe coupled with FAM or Cy3
(Panagene [F1001/F1002]) for 2 min and then at 37C for 12 hr. The probe
was diluted in hybridization buffer (10% dextran sulfate, 50% deionized form-
amide, 23SSC) to the final concentration of 50 mM. Then, cells were washed
with 23SSC at 42C for 20 min. Finally, slides were mounted in ProlongGold
(Life Technologies).
Structural-Illumination-Based Super-Resolution Microscopy and
Telomere Clustering
Telomeres were labeled with a PNA probe using the FISH protocol described
above. Full z stacks were acquired for each nucleus using the 1003 objective.
Telomeric signals were counted on Z projections of nuclei. If more than one te-
lomeric signal could be distinguished within a telomeric focus, then such focus
was scored as a telomeric cluster.
Targeting LacO to Telomeres
Cells were transfected either with GFP-LacI or with GFP-LacI and Flag-
NR2C2-LacI, and the array was visualized either with the GFP or by LacO-spe-
cific FISH. Transfections were performed using the AMAXA nucleofector
device using nucleofector reagent from Mirus according to manufacturers’ in-
structions. Quantification of LacO localization to telomeres was performed
48 hr after transfection.
Transfections and Constructs
We performed triple NR2C/F knockdown because neither single nor double
knockdowns had a strong impact on ALT telomeres, probably because of
redundant function (De´jardin and Kingston, 2009). The triple knockdown was
performed with Stealth RNAi (Life Technologies) using Lipofectamine
RNAiMAX (Life Technologies). The oligonucleotides were transfected twice
within 48 hr. RNAi oligonucleotides used in the experiment were:
siRNA negative control Med GC, NR2F2 [NR2F2MSS235955], NR2C1
[NR2C1HSS110947], and NR2C2 [NR2C2HSS110950]. Flag-NR2C2 and
Flag-NR2C2-DN were kindly provided by Osamu Tanabe. Constructs were
transfected using the AMAXA Cell Line Nucleofector Kit R (VA13 cells) or Kit
V (Saos-2 cells) according to the manufacturer’s instructions.
ITS Induction
Asynchronously growing cells were incubated with bleomycin (Calbiochem,
30 mU/ml) or etoposide (Sigma, 10 mM). After 2 hr, the drug-containing
medium was replaced with fresh medium, and colcemid was added 43 hr after
drug release to prepare chromosome spreads. We quantified the interstitial
telomeric FISH signal on single and (rare) fused chromosomes. In triple
Nr2c/f knockdown, because of the high frequency of chromosomal fusions,
we quantified the interstitial telomeric FISH signal only from single (not fused)
chromosomes to avoid counting fused chromosomes with residual telomere
signal as ITS.Aphidicolin Treatment and TRF1 Knockdown
Cells were treated with low doses (0.3 mM) of Aphidicolin for 24 hr. Aphidicolin
was added 24 hr after a second TRF1 RNAi transfection (two RNAi transfec-
tions within 48 hr). After 20 hr of Aphidicolin treatment, colcemid was added
to medium to induce mitotic arrest. RNAi used for TRF1 knockdown was pur-
chased from Dharmacon (SmartPool RNAi).
Western Blotting
Nuclear extracts from transfected cells were run on 12% Bis-Tris gels (Life
Technologies [NP0341]) and transferred to PVDF membranes using a liquid
transfer system for 2 hr at 300 mA. The membrane was blocked for 30 min
at room temperature in 13 PBS containing 5% milk and then incubated with
primary antibodies diluted 1/1,000 in the same buffer for 2 hr at room temper-
ature, washed twice for 15 min in PBS-0.05%Tween 20, and incubated for 1 hr
with secondary antibodies diluted 1/5,000 in 5%milk-PBSwhich was followed
by two washes in PBS-0.05% Tween 20. Antibodies: aFlag (Sigma [F7425]),
aNR2C2 (PPMX [PP-H0107B-00]), aHMBOX1 (Abcam [ab97643]), aTRF2
(Abcam [ab13579]), aTRF1 (Abcam [ab10579]), aNR2F2 (Abcam [ab50487]),
aNR2C1 (Santa Cruz [sc-9087]), aPCNA (Santa Cruz [sc-25280]), anti-rabbit-
HRP (Sigma [A0545]), anti-mouse-HRP (Sigma [A4416]).
ChIP Sequencing
Cells growing in monolayer were cross-linked in 1% formaldehyde/PBS for
10 min, washed twice in PBS, and scraped in PBS/0.05% Tween. Then cells
were pelleted, washed in PBS, and incubated at 4C in lysis buffer 1 for
10 min, then at room temperature in lysis buffer 2 for 10 min, dounced with a
tight pestle, centrifuged, resuspended in lysis buffer 3 (1 ml/IP for 2 3
107cells) and sonicated (12 pulses of 70% power, 15’’ ON, 45’’ OFF using a
Misonix sonicator) to obtain chromatin fragments of 200 bp. Subsequently,
chromatin was pre-cleared at 4C with 10 ml/ml BSA-blocked Dynabeads
(Life Technologies, a mix 1:1 of protein A and protein G beads) for 30 min
and incubated at 4C with 5 mg antibody/IP overnight. Chromatin was then
incubated with magnetic beads at 4C for 2 hr. Beads were washed five times
with RIPA and once in TE with 50 mM NaCl. Chromatin was eluted from the
beads by incubating in elution buffer with shaking for 30 min. Cross-linking
was removed by overnight incubation at 65C. After RNaseA and proteinase
K treatments, the DNA was extracted with phenol:chloroform and ethanol pre-
cipitation. Isolated DNA was resuspended in water. ChIP experiments were
performed four to six times independently for each antibody. Libraries were
cloned and sequenced by Fasteris SA (Switzerland) using the Illumina strategy
(HiSeq2000, single-end).
Antibodies
anti-TRF2 (SantaCruz Biotechnology, sc-9143); anti-NR2C2-PPMX (PP-
H0107B-00); anti-HMBOX1 (Abcam, ab97643); anti-NR2F2 (Abcam, ab50487).
Buffers Composition
Buffers used for ChIP have been described previously (Lee et al., 2006).
Bioinformatic Analysis
Bioinformatic analysis is described in the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental information includes Extended Experimental Procedures,
seven figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2015.01.044.
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